Robert Drakas

704 total citations
15 papers, 558 citations indexed

About

Robert Drakas is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert Drakas has authored 15 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert Drakas's work include RNA Research and Splicing (5 papers), Ubiquitin and proteasome pathways (3 papers) and RNA and protein synthesis mechanisms (3 papers). Robert Drakas is often cited by papers focused on RNA Research and Splicing (5 papers), Ubiquitin and proteasome pathways (3 papers) and RNA and protein synthesis mechanisms (3 papers). Robert Drakas collaborates with scholars based in United States and Germany. Robert Drakas's co-authors include Renato Baserga, Kazuko Nishikura, Fang Lai, Marco di Prisco, Xiao Tu, Anguo Wu, Guissou A. Dabiri, Fan Lai, Mingli Liu and Jia Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Robert Drakas

15 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Drakas United States 9 497 84 83 47 41 15 558
Karin Mattern Netherlands 12 516 1.0× 50 0.6× 59 0.7× 28 0.6× 32 0.8× 15 689
Luise Stempka Germany 8 358 0.7× 46 0.5× 34 0.4× 54 1.1× 46 1.1× 10 450
Sue-Hwa Lin United States 8 341 0.7× 29 0.3× 103 1.2× 62 1.3× 16 0.4× 8 464
W. John Langlois United States 11 582 1.2× 101 1.2× 129 1.6× 38 0.8× 18 0.4× 13 686
Laurent Bermont France 11 207 0.4× 78 0.9× 78 0.9× 54 1.1× 11 0.3× 23 398
Mark S. Chapman United States 8 255 0.5× 144 1.7× 79 1.0× 47 1.0× 10 0.2× 10 466
Glen Young United States 11 493 1.0× 21 0.3× 107 1.3× 44 0.9× 71 1.7× 13 593
J.M. Holzbeierlein United States 7 272 0.5× 27 0.3× 77 0.9× 66 1.4× 9 0.2× 8 392
Kristopher Krueger United States 8 259 0.5× 32 0.4× 113 1.4× 122 2.6× 20 0.5× 12 423
Agnieszka Piętas Germany 6 383 0.8× 16 0.2× 69 0.8× 135 2.9× 37 0.9× 6 454

Countries citing papers authored by Robert Drakas

Since Specialization
Citations

This map shows the geographic impact of Robert Drakas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Drakas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Drakas more than expected).

Fields of papers citing papers by Robert Drakas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Drakas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Drakas. The network helps show where Robert Drakas may publish in the future.

Co-authorship network of co-authors of Robert Drakas

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Drakas. A scholar is included among the top collaborators of Robert Drakas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Drakas. Robert Drakas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lee, Kyung, Robert Drakas, & John Cijiang He. (2024). Small Molecule Allosteric Inhibitor of HIPK2 as a Novel Therapy against Kidney Fibrosis. Journal of the American Society of Nephrology. 35(6). 809–811. 2 indexed citations
2.
Weaver, David T., et al.. (2023). Abstract 2627: The small molecule KRAS inhibitor, TEB-17231, blocks tumor progression and overcomes KRASG12C inhibitor mediated resistance. Cancer Research. 83(7_Supplement). 2627–2627. 8 indexed citations
3.
Lourenço, André Luiz, Markus‐Frederik Bohn, Byron Hann, et al.. (2023). High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions. mAbs. 15(1). 2184197–2184197. 4 indexed citations
4.
He, Yuanjun, Di Zhu, Kevin L. Greenman, et al.. (2023). Structure–Activity Relationship and Biological Investigation of a REV-ERBα-Selective Agonist SR-29065 (34) for Autoimmune Disorders. Journal of Medicinal Chemistry. 66(21). 14815–14823. 3 indexed citations
5.
Dudkin, Vadim, Cheng Wang, Kenneth L. Arrington, et al.. (2012). Pyridyl aminothiazoles as potent Chk1 inhibitors: Optimization of cellular activity. Bioorganic & Medicinal Chemistry Letters. 22(7). 2613–2619. 6 indexed citations
6.
Dudkin, Vadim, Keith Rickert, Constantine Kreatsoulas, et al.. (2012). Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation rates. Bioorganic & Medicinal Chemistry Letters. 22(7). 2609–2612. 20 indexed citations
7.
Chen, Jia, Anguo Wu, Hongzhi Sun, et al.. (2005). Functional Significance of Type 1 Insulin-like Growth Factor-mediated Nuclear Translocation of the Insulin Receptor Substrate-1 and β-Catenin. Journal of Biological Chemistry. 280(33). 29912–29920. 86 indexed citations
8.
Liu, Mingli, et al.. (2005). 24p3 in differentiation of myeloid cells. Journal of Cellular Physiology. 205(2). 302–309. 8 indexed citations
9.
Drakas, Robert, Marco di Prisco, & Renato Baserga. (2004). A modified tandem affinity purification tag technique for the purification of protein complexes in mammalian cells. PROTEOMICS. 5(1). 132–137. 47 indexed citations
10.
Drakas, Robert, Xiao Tu, & Renato Baserga. (2004). Control of cell size through phosphorylation of upstream binding factor 1 by nuclear phosphatidylinositol 3-kinase. Proceedings of the National Academy of Sciences. 101(25). 9272–9276. 69 indexed citations
11.
Prisco, Marco di, Francesca Santini, Raffaele Baffa, et al.. (2002). Nuclear Translocation of Insulin Receptor Substrate-1 by the Simian Virus 40 T Antigen and the Activated Type 1 Insulin-like Growth Factor Receptor. Journal of Biological Chemistry. 277(35). 32078–32085. 70 indexed citations
12.
Belletti, Barbara, Robert Drakas, Andrea Morrione, et al.. (2002). Regulation of Id1 Protein Expression in Mouse Embryo Fibroblasts by the Type 1 Insulin-like Growth Factor Receptor. Experimental Cell Research. 277(1). 107–118. 19 indexed citations
13.
14.
Dabiri, Guissou A., Fan Lai, Robert Drakas, & Kazuko Nishikura. (1996). Editing of the GLuR-B ion channel RNA in vitro by recombinant double-stranded RNA adenosine deaminase.. The EMBO Journal. 15(1). 34–45. 71 indexed citations
15.
Lai, Fang, Robert Drakas, & Kazuko Nishikura. (1995). Mutagenic Analysis of Double-stranded RNA Adenosine Deaminase, a Candidate Enzyme for RNA Editing of Glutamate-gated Ion Channel Transcripts. Journal of Biological Chemistry. 270(29). 17098–17105. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin Mattern Breakdown of academic impact, for papers by Luise Stempka Breakdown of academic impact, for papers by Sue-Hwa Lin Breakdown of academic impact, for papers by W. John Langlois Breakdown of academic impact, for papers by Laurent Bermont Breakdown of academic impact, for papers by Mark S. Chapman Breakdown of academic impact, for papers by Glen Young Breakdown of academic impact, for papers by J.M. Holzbeierlein Breakdown of academic impact, for papers by Kristopher Krueger Breakdown of academic impact, for papers by Agnieszka Piętas
Rankless by CCL
2026